Bill > HB2103

This bill directs the State Board of Pharmacy to classify xylazine, a sedative and muscle relaxant veterinary drug that has recently gained attention for its role in the opioid epidemic, as a Schedule IV controlled substance. Schedule IV controlled substances are drugs with a lower potential for abuse compared to Schedule III substances, but still require a prescription and careful monitoring. By adding this classification, the bill aims to regulate xylazine more strictly, potentially reducing its misuse and diversion. The bill specifically instructs the State Board of Pharmacy to create and implement rules for this new classification, which will be incorporated into Oregon's existing controlled substances statutes (ORS 475.005 to 475.285). This legislative action appears to be a response to the growing concern about xylazine's increasing presence in illicit drug mixtures and its potential health risks.

Health and Social Services

https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HB2103